Testing an experimental pain reliever in healthy volunteers
Treatments studied
Part of Pain clinical trials.
This study tests an experimental drug called (2R,6R)-HNK given through an IV to see if it can reduce pain caused by heat in healthy volunteers. It will help researchers learn if this drug could be a future pain reliever.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 60 years old and in general good health.
- Be willing to receive an intravenous (IV) medication and follow the study schedule.
- Be right-handed and have no metal implants or devices that could interfere with an MRI scan.
- Have no current or past chronic pain (pain lasting more than 6 months).
- Have no significant mental health conditions like mood or anxiety disorders, or substance use issues.
- Use effective birth control during the study and for a period after, if applicable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new experimental drug (HW243040) in healthy volunteers to see if it is safe and how the body handles it. It includes pain testing to measure how the drug works on pain.
This study tests a new experimental drug (2R,6R)-HNK, a chemical related to ketamine, given by IV infusion to see if it can help people with depression that hasn't improved with other treatments. The goal is to find a new option for people who have not found relief from standard antidepressants.
This study tests how healthy adults respond to different types of pain, such as heat, cold, and a substance that causes a mild burning feeling. The results may help researchers better understand pain and could guide future pain treatments.
This study tests a new medicine called KR25102 to see if it is safe and how the body handles it. It may help develop a treatment for pain.
This Phase 1/2 study tests hydroxynorketamine (a related ketamine-type medicine) to see if it can reduce chronic nerve pain in the arms or legs. You may be able to join if you have nerve pain for more than 3 months and meet safety and health check requirements.
This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.